Showing 20,801 - 20,820 results of 36,417 for search '(( 50 ((a decrease) OR (we decrease)) ) OR ( a ((fold decrease) OR (mean decrease)) ))', query time: 0.84s Refine Results
  1. 20801

    Data_Sheet_3_Knowledge of Symptoms of Acute Myocardial Infarction, Reaction to the Symptoms, and Ability to Perform Cardiopulmonary Resuscitation: Results From a Cross-sectional Su... by Nadja Kartschmit (7148360)

    Published 2022
    “…</p>Results<p>Out of 11 symptoms, the mean of correctly attributed AMI symptoms was 7.3 (standard deviation 1.96). …”
  2. 20802

    Data_Sheet_2_Knowledge of Symptoms of Acute Myocardial Infarction, Reaction to the Symptoms, and Ability to Perform Cardiopulmonary Resuscitation: Results From a Cross-sectional Su... by Nadja Kartschmit (7148360)

    Published 2022
    “…</p>Results<p>Out of 11 symptoms, the mean of correctly attributed AMI symptoms was 7.3 (standard deviation 1.96). …”
  3. 20803

    Table_1_Use of Non-invasive Parameters and Machine-Learning Algorithms for Predicting Future Risk of Type 2 Diabetes: A Retrospective Cohort Study of Health Data From Kuwait.DOCX by Bassam Farran (553880)

    Published 2019
    “…</p><p>Setting: This study was based on data from the Kuwait Health Network (KHN), which integrated primary health and hospital laboratory data into a single system.</p><p>Participants: The study included 1,837 native Kuwaiti Arab individuals (equal proportion of men and women) with mean age as 59.5 ± 11.4 years. …”
  4. 20804
  5. 20805
  6. 20806
  7. 20807

    Table_1_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.XLSX by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  8. 20808

    Image_2_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.JPEG by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  9. 20809

    Table_2_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.DOCX by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  10. 20810

    Table_3_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.DOC by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  11. 20811

    Table_4_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.DOC by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  12. 20812

    Image_1_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.JPEG by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  13. 20813

    Table_5_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.DOCX by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  14. 20814

    Image_3_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.JPEG by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  15. 20815

    Image_4_QSOX2 Is an E2F1 Target Gene and a Novel Serum Biomarker for Monitoring Tumor Growth and Predicting Survival in Advanced NSCLC.TIF by Yaqi Li (2936265)

    Published 2021
    “…</p>Conclusions<p>Our findings demonstrate that QSOX2 is directly regulated by E2F1 in the cell cycle, which is essential for the proliferation of NSCLC cells. Furthermore, QSOX2 is a prognostic indicator for NSCLC and may be developed into a biomarker for monitoring tumor burden and therapeutic progress.…”
  16. 20816

    Aboveground net primary productivity not CO<sub>2</sub> exchange remain stable under three timing of extreme drought in a semi-arid steppe - Fig 2 by Hui Zhang (7197)

    Published 2019
    “…</b> The percentage at the top of the bar represents decreased values of treatments. Data are means±se.</p>…”
  17. 20817

    Table_3_Association between dietary approaches to stop hypertension eating pattern and lung cancer risk in 98,459 participants: results from a large prospective study.docx by Zhiyong Zhu (2559349)

    Published 2023
    “…Participants in the highest quartile in the fully adjusted model had a relatively decreased risk of developing lung cancer in comparison to those in the lowest quartile (HR<sub>quartile 4 versus 1</sub>: 0.647; 95% CI: 0.557, 0.752; P<sub>trend</sub> < 0.001). …”
  18. 20818

    Table_1_Association between dietary approaches to stop hypertension eating pattern and lung cancer risk in 98,459 participants: results from a large prospective study.docx by Zhiyong Zhu (2559349)

    Published 2023
    “…Participants in the highest quartile in the fully adjusted model had a relatively decreased risk of developing lung cancer in comparison to those in the lowest quartile (HR<sub>quartile 4 versus 1</sub>: 0.647; 95% CI: 0.557, 0.752; P<sub>trend</sub> < 0.001). …”
  19. 20819

    Table_2_Association between dietary approaches to stop hypertension eating pattern and lung cancer risk in 98,459 participants: results from a large prospective study.DOCX by Zhiyong Zhu (2559349)

    Published 2023
    “…Participants in the highest quartile in the fully adjusted model had a relatively decreased risk of developing lung cancer in comparison to those in the lowest quartile (HR<sub>quartile 4 versus 1</sub>: 0.647; 95% CI: 0.557, 0.752; P<sub>trend</sub> < 0.001). …”
  20. 20820

    Impact of 8-MOP concentration (0 ng/ml, 200 ng/ml, or 300 ng/ml) on cellular response after a 2 J/cm<sup>2</sup> UVA dose. by Marie Laulhé (6416483)

    Published 2019
    “…<p>(A) Percentage of Annexin-V+ cells measured daily up to 2 days after irradiation. …”